0003-3170 0003-3170 S0003-31702020000300004 10.20960/angiologia.00112 Spain Spain Spain 00 06 2020 00 06 2020 72 3 135 144

1 STEPH Study Group 2014 12 831-8 2 2017 1 223-30 3 2005 3 1459-66 4 2005 3 1149-51 5 2001 86 452-63 6 2003 37 834-8 7 1993 46 633-9 8 1998 80 239-41 9 1997 157 1822-4 10 1998 27 338-43 11 2005 29 10-7 12 2003 9 393-7 13 2009 145 753-7 14 1999 30 1113-5 15 2018 14 129-35 16 2017 15 2176-83 17 OPTIMEV-SFMV investigators 2018 171 179-86 18 POST (Prospective Observational Superficial Thrombophlebitis) Study Group 2010 152 218-24 19 2004 9 1-6 20 2003 37 421-7 21 2001 26 16-22 22 2004 29 263-72 23 2008 123 194-9 24 2009 28 298-302 25 2009 38 167-70 26 2011 63 25-30 27 2018 23 187-9 28 2019 29 2007 58 Suppl 1 Suppl 1 7S-14S 30 1994 43 160-6 31 1999 50 523-9 32 2002 87 523-7 33 2003 37 415-20 34 2003 10 375-8 35 Superficial Thrombophlebitis Treated By Enoxaparin Study Group 2003 163 1657-63 36 Vesalio Investigators Group 2005 3 1152-7 37 2005 56 9-17 38 2009 24 56-60 39 CALISTO Study Group 2010 363 1222-32 40 STEFLUX Investigators 2012 10 1026-35 41 2012 10 833-9 42 2015 66 381-6 43 2017 2017 223-330 44 SeVEN Collaborators 2018 33 636-45 45 2005 90 672-7 46 2006 32 737-43 47 2007 2 48 2012 3 49 2013 4 50 2018 2 51 2018 320 2367-8 52 2018 6 109-17 53 2019 119 479-89 54 2012 141 321-9 55 2004 126 3 Suppl 3 Suppl 401S-28S 56 American College of Chest Physicians 2008 133 6 Suppl 6 Suppl 454S-545S 57 2012 141 2 Suppl 2 Suppl e419S-96S 58 2019 45 187-96